1 Min Read
Jan 9 (Reuters) - Nektar Therapeutics:
* NEKTAR THERAPEUTICS SAYS BASED ON PRELIMINARY ESTIMATES, AS OF DEC 31, 2017, COMPANY HAD CASH AND INVESTMENTS OF $353.2 MILLION - SEC FILING Source text: [bit.ly/2AJ8qCb] Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.